跳至主要内容
临床试验/JPRN-jRCTs031190160
JPRN-jRCTs031190160已完成3 期

evetIracetam vs. Fosphenytoine for status epilepticus: multi-center randomised non-blinded control trial - IENE ECT with LIFE

Inoue Yoshiaki0 个研究点目标入组 176 人开始时间: 2019年12月16日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
176

研究概览

简要总结

The efficacy of LEV was similar to that of FPHT for the treatment of adult SE following the administration of diazepam. Since it was associated with fewer serious adverse event, LEV is recommended as a second-line treatment for SE as an alternative to phenytoin/FPHT.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • status epilepticus with convulsion, who were transfered by ambulance
  • The difinition of status epilepticus is as follows; over 5 minutes of continuous seizures, or over 2 minutes discrete seizures between which there is incomplete recovery of consciousness over JCS II-30
  • exclude non-convulsive seizure

排除标准

  • under 20 years old
  • patients who entried this study in the past
  • patients in whom informed consent can not be obtained from proxies (If proxies can not be found, the study is performed and the consent is obtained after action.
  • already intubated patients before treatment
  • allergy to fosphenytoin or levetiracetam
  • pseudo-seizure
  • medical doctor considered inapropriate

研究者

发起方
Inoue Yoshiaki

相似试验